annual EBIT:
-$241.60M-$64.69M(-36.57%)Summary
- As of today (May 29, 2025), NAMS annual earnings before interest & taxes is -$241.60 million, with the most recent change of -$64.69 million (-36.57%) on December 31, 2024.
- During the last 3 years, NAMS annual EBIT has fallen by -$200.22 million (-483.94%).
- NAMS annual EBIT is now -3534.22% below its all-time high of -$6.65 million, reached on December 1, 2020.
Performance
NAMS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$68.92M+$42.82M(+38.32%)Summary
- As of today (May 29, 2025), NAMS quarterly earnings before interest & taxes is -$68.92 million, with the most recent change of +$42.82 million (+38.32%) on March 31, 2025.
- Over the past year, NAMS quarterly EBIT has dropped by -$13.44 million (-24.23%).
- NAMS quarterly EBIT is now -188.78% below its all-time high of -$23.87 million, reached on September 30, 2024.
Performance
NAMS quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$255.94M-$13.44M(-5.54%)Summary
- As of today (May 29, 2025), NAMS TTM earnings before interest & taxes is -$255.94 million, with the most recent change of -$13.44 million (-5.54%) on March 31, 2025.
- Over the past year, NAMS TTM EBIT has dropped by -$62.17 million (-32.09%).
- NAMS TTM EBIT is now -562.56% below its all-time high of -$38.63 million, reached on March 31, 2023.
Performance
NAMS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NAMS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.6% | -24.2% | -32.1% |
| 3 y3 years | -483.9% | - | - |
| 5 y5 years | -3534.2% | - | - |
NAMS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -981.1% | at low | -188.8% | +38.3% | -562.6% | at low |
| 5 y | 5-year | -3534.2% | at low | -188.8% | +38.3% | -562.6% | at low |
| alltime | all time | -3534.2% | at low | -188.8% | +38.3% | -562.6% | at low |
NAMS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$68.92M(-38.3%) | -$255.94M(+5.5%) |
| Dec 2024 | -$241.60M(+36.6%) | -$111.74M(+368.2%) | -$242.49M(+33.4%) |
| Sep 2024 | - | -$23.87M(-53.6%) | -$181.75M(-11.8%) |
| Jun 2024 | - | -$51.40M(-7.4%) | -$206.16M(+6.4%) |
| Mar 2024 | - | -$55.48M(+8.8%) | -$193.76M(+9.5%) |
| Dec 2023 | -$176.91M | -$51.00M(+5.6%) | -$176.91M(+40.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$48.28M(+23.8%) | -$125.91M(+62.2%) |
| Jun 2023 | - | -$39.00M(+1.0%) | -$77.63M(+101.0%) |
| Mar 2023 | - | -$38.63M | -$38.63M |
| Dec 2022 | -$22.35M(-46.0%) | - | - |
| Dec 2021 | -$41.37M(+522.4%) | - | - |
| Dec 2020 | -$6.65M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual EBIT year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly EBIT year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM EBIT year-on-year change?
What is NewAmsterdam Pharma Company NV annual earnings before interest & taxes?
The current annual EBIT of NAMS is -$241.60M
What is the all time high annual EBIT for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual earnings before interest & taxes is -$6.65M
What is NewAmsterdam Pharma Company NV annual EBIT year-on-year change?
Over the past year, NAMS annual earnings before interest & taxes has changed by -$64.69M (-36.57%)
What is NewAmsterdam Pharma Company NV quarterly earnings before interest & taxes?
The current quarterly EBIT of NAMS is -$68.92M
What is the all time high quarterly EBIT for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly earnings before interest & taxes is -$23.87M
What is NewAmsterdam Pharma Company NV quarterly EBIT year-on-year change?
Over the past year, NAMS quarterly earnings before interest & taxes has changed by -$13.44M (-24.23%)
What is NewAmsterdam Pharma Company NV TTM earnings before interest & taxes?
The current TTM EBIT of NAMS is -$255.94M
What is the all time high TTM EBIT for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM earnings before interest & taxes is -$38.63M
What is NewAmsterdam Pharma Company NV TTM EBIT year-on-year change?
Over the past year, NAMS TTM earnings before interest & taxes has changed by -$62.17M (-32.09%)